Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Rhea-AI Summary

Lifecore (NASDAQ: LFCR) granted an inducement restricted stock unit award for 18,500 shares to a newly hired employee effective March 25, 2026. The award was approved by the compensation committee under Lifecore’s Equity Inducement Plan and Nasdaq Listing Rule 5635(c)(4).

The RSUs vest and settle on the third anniversary of the grant date, subject to continued employment, and are governed by an award agreement and the Inducement Plan.

News Market Reaction – LFCR

-5.43%

1 alert

-5.43% Session close to close

$138.48M Market Cap

0.0x Rel. Volume

In the Mar 27 session, LFCR declined 5.43%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved -5.4% in the session following this news. A negative reaction despite the routine na...

Analysis

The stock moved -5.4% in the session following this news. A negative reaction despite the routine nature of this inducement grant would fit a pattern where the stock has sometimes moved sharply on corporate updates, such as the -24.39% move after the latest earnings release. The grant of 18,500 RSUs under Nasdaq Listing Rule 5635(c)(4) modestly adds to potential future share count, which some investors may view cautiously alongside previously registered resale capacity of over 20,456,637 shares and existing preferred and term-loan obligations.

Key Figures

RSU inducement grant: 18,500 shares

1 metrics

RSU inducement grant 18,500 shares Restricted stock units granted under Equity Inducement Plan to a new hire

Historical Context

5 past events · Latest: Mar 23 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Mar 23	Commercial agreement	Positive	+0.8%	New CDMO site transfer deal with potential revenue within 24 months.
Mar 16	Earnings report	Positive	-24.4%	Stronger revenues, margins, liquidity and 2026 guidance update.
Mar 10	Conference participation	Neutral	-1.3%	Announcement of participation in KeyBanc healthcare virtual forum.
Mar 09	Earnings date set	Neutral	-1.1%	Scheduling announcement for Q4 and transition-period results call.
Mar 04	Development deal	Positive	-0.6%	Agreement with Indomo to support DT-001 engineering and clinical batches.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent news has often been operationally positive, yet reactions have been muted or negative, including a sharp selloff on the latest earnings despite improved metrics.

Recent Company History

Over recent months, Lifecore reported several business wins and operational updates. A March 16 earnings release highlighted higher revenues, improved margins, and positive 2026 guidance but saw a -24.39% reaction. Commercial agreements on March 4 and March 23 to support new programs and a site transfer produced only modest moves (within about 1%). Conference participation and an earnings-date announcement also drew small, slightly negative reactions. Against this backdrop, today’s Nasdaq Rule 5635(c)(4) inducement grant fits into an active period for corporate and governance-related actions.

Key Terms

restricted stock unit, equity inducement plan, nasdaq listing rule 5635(c)(4), cdmo

4 terms

restricted stock unit financial

"Lifecore granted a restricted stock unit (“RSU”) award with respect to 18,500 shares"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

equity inducement plan financial

"under Lifecore’s Equity Inducement Plan, as amended (the “Inducement Plan”)"

An equity inducement plan is a program that gives new hires or targeted employees stock, restricted shares, or stock options as a hiring or retention reward, often separate from the company’s regular long-term incentive plans. Think of it as a signing bonus paid in company stock: it helps attract and keep talent but matters to investors because it can dilute existing shares, change executive incentives, and affect future earnings through compensation expense.

nasdaq listing rule 5635(c)(4) regulatory

"in accordance with Nasdaq Listing Rule 5635(c)(4) under the Inducement Plan"

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

cdmo technical

"a fully integrated injectables contract development and manufacturing organization (“CDMO”)"

A contract development and manufacturing organization (CDMO) is a company that provides specialized services to help develop and produce pharmaceutical products for other businesses. Think of it as a contract factory that takes a company's recipe and makes the product on their behalf. For investors, CDMOs are important because they support the growth of pharmaceutical companies and can be key partners in bringing new medicines to market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CHASKA, Minn., March 26, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that effective on March 25, 2026, Lifecore granted a restricted stock unit (“RSU”) award with respect to 18,500 shares of its common stock under Lifecore’s Equity Inducement Plan, as amended (the “Inducement Plan”) to a newly hired employee of Lifecore. The RSU award was granted pursuant to the offer letter between Lifecore and the employee, and as a material inducement to the employee joining Lifecore.

The RSU award was approved by Lifecore’s compensation committee and was granted as inducement equity award in accordance with Nasdaq Listing Rule 5635(c)(4) under the Inducement Plan.

The RSUs will vest and be settled on the third anniversary of the grant date, subject to continued employment. The RSU award is governed by an award agreement and the Inducement Plan.

About Lifecore Biomedical

Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.

Lifecore Biomedical, Inc. Contact Information:

Vida Strategic Partners
Stephanie Diaz (Investors & Media)
415-675-7401
sdiaz@vidasp.com

Lifecore Biomedical
Ryan D. Lake (CFO)
952-368-6244
ryan.lake@lifecore.com

FAQ

What did Lifecore (LFCR) announce on March 26, 2026 about an inducement grant?

Lifecore announced a restricted stock unit award for 18,500 shares to a new hire, effective March 25, 2026. According to the company, the award was approved by the compensation committee under the Equity Inducement Plan and Nasdaq Listing Rule 5635(c)(4).

How and when do the 18,500 RSUs granted by Lifecore (LFCR) vest?

The RSUs vest and are settled on the third anniversary of the grant date, subject to continued employment. According to the company, vesting occurs only if the employee remains employed through that third-year settlement date.

Why did Lifecore (LFCR) issue the RSU award under Nasdaq Listing Rule 5635(c)(4)?

The RSU was issued as a material inducement to recruit a newly hired employee, in compliance with Nasdaq Rule 5635(c)(4). According to the company, the award follows the Inducement Plan and was compensation committee approved.

Does the Lifecore (LFCR) RSU award dilute existing shareholders and by how much?

The announcement specifies 18,500 RSUs granted but does not state total shares outstanding or dilution percentage. According to the company, the award terms are governed by the Inducement Plan and the award agreement.

Who approved Lifecore's (LFCR) inducement RSU award and under what plan?

Lifecore's compensation committee approved the RSU award under the company’s Equity Inducement Plan. According to the company, the grant was made pursuant to the employee offer letter and Nasdaq Listing Rule 5635(c)(4).